International coffee futures rose as high as 70% during the year. As of December 12, Beijing time, the price of US ICE coffee futures had risen by nearly 70% during the year, and once hit a high of 345.55 cents/pound on December 10, a record high. At the same time, the price of Arabica coffee futures on the New York Futures Exchange also reached $3.434 per pound, exceeding the record high set in 1977. As for the reasons for the soaring international coffee futures prices, a futures industry source revealed that the price increase of coffee beans was mainly due to weather changes and supply chain disruptions. Brazil, the world's largest coffee producer (accounting for one third of the world's output), has experienced severe drought and frost in recent years, resulting in a sharp decline in coffee production. (CBN)Institution: The Swiss National Bank does not need to cut interest rates sharply again. Melanie Debono, a macroeconomic analyst at Pantheon, wrote in a report that the Swiss National Bank does not need to cut borrowing costs sharply again. Earlier, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. Most analysts had expected a more cautious rate cut of 25 basis points. Debono said that there may be further relaxation after this move, but only a little. Pantheon Macroeconomics predicts that the Swiss National Bank will cut interest rates by 25 basis points again in March next year.OPENAI said that it is working hard to solve the current fault problem.
Hongjiu Fruit: Jiang Zongying, the controlling shareholder and executive director, pledged 21 million H shares of the company. Hongjiu Fruit (06689) announced that the company had learned that Ms. Jiang Zongying, the controlling shareholder and executive director of the company, had pledged the company's shares on December 11, 2024. Because the company failed to return the relevant funds to the subscriber within the time limit stipulated in the termination agreement, Ms. Jiang pledged 21 million H shares of the company to the subscriber as the company's subsequent refund of the relevant funds to the subscriber.Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.Spot gold just broke through the $2,710.00/oz mark, and the latest price was $2,709.91/oz, down 0.29% in the day; COMEX gold futures main force recently reported $2,744.30 per ounce, down 0.45% in the day.
Li Tie's case will be pronounced in the first instance tomorrow. The court has informed his defender of the well-known football player Li Tie, the former head coach of China National Men's Football Team (hereinafter referred to as "China Men's Football Team"), that the case will be pronounced in public by the Intermediate People's Court of Xianning City, Hubei Province tomorrow, that is, December 13, 2024, Beijing time. In the previous court hearing, although Li Tie said that he "pleaded guilty and repented", he did not "plead guilty and admit punishment". (Economic Observer)Wanchen Group: It is planned to purchase 16 "New Zero Help" software systems of Nanjing Zhongcheng for 27.7031 million yuan. Wanchen Group announced that in order to meet the needs of the company and its holding subsidiaries to carry out daily business activities, the company plans to purchase 16 "New Zero Help" software systems held by Nanjing Zhongcheng at a transaction price of 27.7031 million yuan (including tax). Nanjing Zhongcheng is a related party of the company, and this transaction constitutes a related party transaction. According to the announcement, the software system is specially designed for retail and wholesale enterprises, mainly for medium and large retail enterprises.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.
Strategy guide 12-13
Strategy guide
12-13